Back to screener
Healthcare · Drug Manufacturers - Specialty & Generic
Sakar Healthcare Limited
₹1,179.80
▲ 50.25 (+4.45%) today
Latest quote · Yahoo Finance
Market Cap
₹2.59K Cr
P/E (TTM)
85.6
P/B
8.1
Book Value
₹145.98
ROE
11.3%
Div Yield
—
D/E
0.22
EPS (TTM)
₹13.78
52W High
₹1,211.00
52W Low
₹333.50
Sales Growth
+38.40%
Profit Growth
+119.00%
Day High
₹1,190.50
Day Low
₹1,148.00
Volume
1,47,455
Fundamentals refreshed 5 hr ago · Statements just now · Source: Yahoo Finance
Quick Take
- • Trading at 85.6× trailing earnings (28.8× forward)
- • Moderate ROE at 11.3%
- • Low leverage (D/E 0.22)
- • No dividend data
- • Operating margin 20.2% · Net margin 13.3%
- • Profit growth +119.00% YoY · Beta 0.44
Employees: 435
Latest quarter · Mar 2026
| ₹ Cr | Mar 2026 | QoQ | YoY |
|---|---|---|---|
| Revenue | 71 | +1.43% | +42.00% |
| Operating Profit | 26 | +36.84% | +62.50% |
| Net Profit | 11 | +10.00% | +83.33% |
| EPS (₹) | 4.96 | +8.06% | +87.17% |
OPM 37.1% · Net margin 15.5% · prev quarter OPM 27.2%
Loading shareholding pattern…
Loading block / bulk / insider deals…
About the company
From latest AR & concall Reading the latest annual report and earnings call… (1–3 min on first visit)
Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company offers general and oncology products in various forms, such as liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. It also exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.
